U.S. Food and Drug Administration
About U.S. Food and Drug Administration
The U.S. Food and Drug Administration (FDA) is a federal regulatory agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. It also oversees the safety of the nation’s food supply, cosmetics, and radiation-emitting products. The FDA develops and enforces regulations, conducts inspections, and provides guidance to industry and consumers to promote safe and effective products. It operates nationwide with activities and programs across health, safety, and science, including international programs.
Recent News
Antibacterial Susceptibility Test Interpretive Criteria
Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers
FDA Testing Shows U.S. Infant Formula Is Safe, with Undetectable or Very Low Chemical Contamination
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
Denali Therapeutics Secures FDA Approval for AVLAYAH, First Gene Therapy for Hunter Syndrome
FDA Knocks Back AstraZeneca's Self-Injected Lupus Drug
How Do Recent Actions From FDA Provide Insight to the Agency's Enforcement Posture?
Hospitals Could Earn More for Buying US-Made Drugs, CMS Proposes
FDA Launches Pilot Programme to Boost US Manufacturing
Sandoz Q1 Net Sales Rise 3% to $2.76 Bn, Biosimilars Up 18% and 2026 Guidance Reaffirmed
FDA Says It Explained Issues Early on for Corcept's Rejected Cushing's Syndrome Drug
Infant Formula Recalled because of Contamination with Cereulide
FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine
FDA Warned Corcept of ‘Significant Review Issues’ for Rejected Drug in Early Meetings
Development of Local Anesthetic Drug Products With Prolonged Duration of Effect
Breakthrough Stem Cell Therapy Shows Promise for Parkinson’s Disease
FDA's Proposed Peptide Rule Change Boosts Hims & Hers, Sends Mixed Signals Across Pharma
Influenza Vaccine Effectiveness Lower In Recent Months, Preliminary Data Show
IFAST Diagnostics Bags £5M to Speed up Infection Testing and Tackle Antimicrobial Resistance
REGENXBIO Delay Could Put Denali in Pole Position for Hunter Syndrome Approval
Recent Deals
No recent deals for this company.